LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee
BEIJING, Aug. 28, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, ...
How is the proposed acquisition likely to affect the capital structure, dilution risk, and earnings outlook for existing shareholders?
When will the special committee be formed and what is the expected timeline for due diligence and shareholder approval?
What are the key terms and valuation of the revised preliminary non‑binding acquisition proposal?
13 days ago